Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Systems Research for a New Era: Launch Editorial.

Health systems and reform·2026
Same author

Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger.

PLOS global public health·2026
Same author

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same author

Assessing the sustainability of Rwanda's mass drug administration program for schistosomiasis and soil-transmitted helminthiasis: A mixed-methods application of the program sustainability assessment tool.

PLoS neglected tropical diseases·2026
Same author

Maturity assessment of KenyaEMR: advancing digital health solutions through continuous improvement in Kenya.

BMC health services research·2026
Same author

Identifying and mapping key relationships and communication pathways influencing farmers' antibiotic use in production animals: a scoping review.

One health outlook·2026

Related Experiment Video

Updated: Jun 12, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Optimizing HIV treatment programs.

Sergio Bautista-Arredondo1, Tyler E Martz, Veronika J Wirtz

  • 1Center for Evaluation Research and Surveys, National Institute of Public Health, Cuernavaca, Morelos, Mexico. sbautista@correo.insp.mx <sbautista@correo.insp.mx>

Current Opinion in HIV and AIDS
|June 12, 2010
PubMed
Summary
This summary is machine-generated.

Optimizing HIV treatment programming requires explicit decisions on access, initiation, and adherence, involving patients, practitioners, and managers. This approach maximizes resource benefits and individual outcomes in resource-limited settings.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Experiment Videos

Last Updated: Jun 12, 2026

Comprehensive &amp; Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Area of Science:

  • Public Health
  • Health Services Research
  • Infectious Disease Management

Background:

  • Growing demand for HIV treatment strains limited resources globally.
  • Current research on HIV treatment adherence primarily focuses on patient-level factors.

Purpose of the Study:

  • To highlight the need for optimizing HIV treatment programming for better outcomes and resource utilization.
  • To emphasize the importance of strategic decisions at all levels of care.

Main Methods:

  • Literature review on HIV treatment programming and adherence.
  • Analysis of decision-making processes in HIV care delivery.

Main Results:

  • Existing research on HIV treatment adherence is insufficient, often overlooking systemic and programmatic factors.
  • Decisions regarding treatment access, initiation, drug regimens, and discontinuation significantly impact outcomes.

Conclusions:

  • Maximizing benefits from limited resources necessitates explicit decisions on treatment access, initiation, drug combinations, and termination.
  • Effective HIV treatment optimization requires collaboration among program managers, health practitioners, and patients.
  • Addressing both incentives and barriers to treatment adherence is crucial for resource maximization.